Zenas BioPharma, Inc. 2020 Equity Incentive Plan Non-Statutory Share Option Agreement (Non-Employee Directors)Non-Statutory Share Option Agreement • August 22nd, 2024 • Zenas BioPharma, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 22nd, 2024 Company IndustryThis agreement (this “Agreement”) evidences a share option granted by Zenas BioPharma, Inc. (the “Company”) to the individual named above (the “Participant”), pursuant to and subject to the terms of the Zenas BioPharma, Inc. 2020 Equity Incentive Plan (as from time to time amended and in effect, the “Plan”). Except as otherwise defined herein, all capitalized terms used herein have the same meaning as in the Plan.
LianBio 2021 Equity Incentive Plan Non-Statutory Share Option AgreementNon-Statutory Share Option Agreement • March 31st, 2022 • LianBio • Pharmaceutical preparations
Contract Type FiledMarch 31st, 2022 Company IndustryThis agreement (this “Agreement”) evidences a share option granted by LianBio, an exempted company organized under the laws of the Cayman Islands (the “Company”) to the individual named above (the “Participant”), pursuant to and subject to the terms of the LianBio 2021 Equity Incentive Plan (as from time to time amended and in effect, the “Plan”). Except as otherwise defined herein, all capitalized terms used herein have the same meaning as in the Plan.
Form of NON-STATUTORY SHARE OPTION AGREEMENTNon-Statutory Share Option Agreement • February 8th, 2024 • Bit Digital, Inc • Finance services
Contract Type FiledFebruary 8th, 2024 Company IndustryTHIS NON-STATUTORY SHARE OPTION AGREEMENT is made as of _______, 2023, by and between Bit Digital, Inc., a Cayman Islands exempted company, having its principal executive offices at 33 Irving Place, New York, NY 10003 (the “Grantor”), and _______________ _______________, an individual residing at [___________________________] (the “Optionee”).
LIANBIO NON-STATUTORY SHARE OPTION AGREEMENT – NON-EMPLOYEE DIRECTORSNon-Statutory Share Option Agreement • October 8th, 2021 • LianBio • Pharmaceutical preparations
Contract Type FiledOctober 8th, 2021 Company IndustryThis agreement (this “Agreement”) evidences a share option granted by LianBio, an exempted company organized under the laws of the Cayman Islands (the “Company”) to the individual named above (the “Participant”), pursuant to and subject to the terms of the LianBio 2021 Equity Incentive Plan (as from time to time amended and in effect, the “Plan”). Except as otherwise defined herein, all capitalized terms used herein have the same meaning as in the Plan.